How a Doctor Saved His Own Life 🤯

Published on September 29, 2025
Duration: 0:41

This entry details Dr. David Fajgenbaum's personal battle with Idiopathic Multicentric Castleman Disease, a life-threatening condition. It covers his diagnosis, critical organ failure, and the experimental use of Sirolimus, an mTOR inhibitor, which led to his sustained remission for over 11.5 years. The content highlights his medical expertise and resilience in overcoming a rare pathology.

Quick Summary

Dr. David Fajgenbaum survived Idiopathic Multicentric Castleman Disease, a rare condition causing organ failure, by using the immunosuppressant Sirolimus. This experimental treatment, never before used for his condition, has kept him in remission for over 11.5 years, showcasing a remarkable medical recovery.

Chapters

  1. 00:00Critical Organ Failure
  2. 00:15Castleman Disease Diagnosis
  3. 00:25Experimental Treatment and Recovery

Frequently Asked Questions

What is Idiopathic Multicentric Castleman Disease?

Idiopathic Multicentric Castleman Disease (iMCD) is a rare and serious autoimmune disorder where the immune system mistakenly attacks the body's organs, leading to inflammation and potential organ failure. Dr. David Fajgenbaum was diagnosed with this condition.

How did Dr. David Fajgenbaum treat his Castleman Disease?

Dr. Fajgenbaum, a medical doctor himself, proposed and underwent treatment with Sirolimus, an mTOR inhibitor and immunosuppressant drug. This was an experimental approach as the drug had not been previously used for this specific condition.

What was the outcome of Dr. Fajgenbaum's treatment?

The experimental treatment with Sirolimus proved highly successful for Dr. Fajgenbaum. He has been in remission from Idiopathic Multicentric Castleman Disease for over 11.5 years, a remarkable outcome for such a severe condition.

What is Sirolimus?

Sirolimus, also known as Rapamycin, is a powerful medication classified as an mTOR inhibitor and immunosuppressant. It is typically used to prevent organ transplant rejection but was used off-label in Dr. Fajgenbaum's case for Castleman Disease.

More General Videos You Might Like

More from Shawn Ryan Show

View all →